Literature DB >> 12173027

Gaucher disease in Romanian patients: incidence of the most common mutations and phenotypic manifestations.

Cristina Drugan1, Lucia Procopciuc, Gheorghe Jebeleanu, Paula Grigorescu-Sido, Jane Dussau, Livia Poenaru, Catherine Caillaud.   

Abstract

Gaucher disease (GD) is an inherited glycolipid storage disorder resulting from the deficiency of glucocerebrosidase. It is the most frequent lysosomal storage disease in Romania, accounting for 70% of all lysosomal disorders diagnosed since 1997 in this country. The prevalence of six common mutations (N370S, L444P, R463C, 84GG, recNciI and recTL) and their phenotypic impact were studied in 20 type 1 GD patients of non-Jewish origin. Mutation analysis identified 77.8% of the GD alleles. The N370S mutation had the highest prevalence (50%), followed by the L444P (22.2%) and the recNciI (5.6%) alleles. Mutations R463C, 84GG and recTL have not been found in our patients. Rare or novel mutations likely accounted for 22.2% of the disease-producing uncharacterised alleles. Our study indicates a high prevalence of type 1 among Romanian GD patients. Clinical phenotype and disease severity were evaluated according to the standardised severity score index. Genotype-phenotype correlations were similar to those reported for other Caucasian non-Jewish populations. The absence of neuronopathic disease in patients presenting at least one copy of the N370S allele was confirmed, but the relative mildness of N370S homozygotes was not a constant feature among our patients. The presence of the L444P or of uncharacterised sporadic mutations was always associated with severe clinical manifestations, even in compound heterozygotes with the N370S allele. A large degree of phenotypic variability was observed in patients displaying the same genotype. The particularities of genotype-phenotype correlations may suggest the impact of other genetic or non-genetic factors on the clinical picture.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12173027     DOI: 10.1038/sj.ejhg.5200845

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  11 in total

1.  Glucosidase acid beta gene mutations in Egyptian children with Gaucher disease and relation to disease phenotypes.

Authors:  Zakarya El-Morsy; Mohamed T Khashaba; Othman El-Sayed Soliman; Sohier Yahia; Dina Abd El-Hady
Journal:  World J Pediatr       Date:  2011-06-01       Impact factor: 2.764

2.  Dynamic changes of lipid profile in Romanian patients with Gaucher disease type 1 under enzyme replacement therapy: a prospective study.

Authors:  Anca Zimmermann; Paula Grigorescu-Sido; Heidi Rossmann; Karl J Lackner; Cristina Drugan; Camelia Al Khzouz; Simona Bucerzan; Ioana Naşcu; Tim Zimmermann; Daniel Leucuţa; Matthias M Weber
Journal:  J Inherit Metab Dis       Date:  2012-09-14       Impact factor: 4.982

3.  A germline or de novo mutation in two families with Gaucher disease: implications for recessive disorders.

Authors:  Hamid Saranjam; Sameer S Chopra; Harvey Levy; Barbara K Stubblefield; Emerson Maniwang; Ian J Cohen; Hagit Baris; Ellen Sidransky; Nahid Tayebi
Journal:  Eur J Hum Genet       Date:  2012-06-20       Impact factor: 4.246

4.  Gaucher disease in North Macedonia: Unexpected prevalence of the N370S GBA1 allele with attenuated disease expression.

Authors:  Nevenka Ridova; Sanja Trajkova; Biljana Chonevska; Zlate Stojanoski; Martin Ivanovski; Marija Popova-Labachevska; Simona Stojanovska-Jakimovska; Venko Filipche; Aspazija Sofijanova; Irina Panovska-Stavridis
Journal:  Mol Genet Metab Rep       Date:  2022-07-08

5.  Novel mutations in the glucocerebrosidase gene of Indian patients with Gaucher disease.

Authors:  Chitra Ankleshwaria; Mehul Mistri; Ashish Bavdekar; Mamta Muranjan; Usha Dave; Parag Tamhankar; Varun Khanna; Eresha Jasinge; Sheela Nampoothiri; Suresh Edayankara Kadangot; Frenny Sheth; Sarita Gupta; Jayesh Sheth
Journal:  J Hum Genet       Date:  2014-02-13       Impact factor: 3.172

6.  Correlation of MRI-Based bone marrow burden score with genotype and spleen status in Gaucher's disease.

Authors:  Robert F DeMayo; Andrew H Haims; Matthew C McRae; Ruhua Yang; Pramod K Mistry
Journal:  AJR Am J Roentgenol       Date:  2008-07       Impact factor: 3.959

7.  Outcome of enzyme replacement therapy in patients with Gaucher disease type I. The Romanian experience.

Authors:  P Grigorescu Sido; C Drugan; V Cret; C Al-Kzouz; C Denes; C Coldea; A Zimmermann
Journal:  J Inherit Metab Dis       Date:  2007-08-20       Impact factor: 4.982

8.  Early manifestations of type 1 Gaucher disease in presymptomatic children diagnosed after parental carrier screening.

Authors:  Amy C Yang; Louise Bier; Jessica R Overbey; Jessica Cohen-Pfeffer; Khyati Desai; Robert J Desnick; Manisha Balwani
Journal:  Genet Med       Date:  2016-10-13       Impact factor: 8.822

9.  Splenomegaly, cardiomegaly, and osteoporosis in a child with Gaucher disease.

Authors:  J J Sheth; C M Ankleshwaria; M A Mistri; N Nanavaty; S J Mehta
Journal:  Case Rep Pediatr       Date:  2011-09-29

10.  Gaucher disease in Syrian children: common mutations identification, and clinical futures.

Authors:  Diana Alasmar
Journal:  Ann Saudi Med       Date:  2015 Mar-Apr       Impact factor: 1.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.